Anti–interleukin 12 treatment regulates apoptosis of Th1 T cells in experimental colitis in mice
- 1 November 1999
- journal article
- Published by Elsevier in Gastroenterology
- Vol. 117 (5) , 1078-1088
- https://doi.org/10.1016/s0016-5085(99)70392-6
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- RETRACTED: The Fas/Fas Ligand Pathway and Bcl-2 Regulate T Cell Responses to Model Self and Foreign AntigensImmunity, 1998
- Interleukin 4 (IL-4) or IL-7 Prevents the Death of Resting T Cells: Stat6 Is Probably Not Required for the Effect of IL-4The Journal of Experimental Medicine, 1997
- Experimental granulomatous colitis in mice is abrogated by induction of TGF-beta-mediated oral tolerance.The Journal of Experimental Medicine, 1996
- T helper type 1/T helper type 2 cytokines and T cell death: preventive effect of interleukin 12 on activation-induced and CD95 (FAS/APO-1)-mediated apoptosis of CD4+ T cells from human immunodeficiency virus-infected persons.The Journal of Experimental Medicine, 1995
- Antibodies to interleukin 12 abrogate established experimental colitis in mice.The Journal of Experimental Medicine, 1995
- Ulcerative colitis and adenocarcinoma of the colon in Gαi2-deficient miceNature Genetics, 1995
- Interleukin‐12 is required for interferon‐γ production and lethality in lipopolysaccharide‐induced shock in miceEuropean Journal of Immunology, 1995
- Inhibition of Thl responses prevents inflammatory bowel disease in scid mice reconstituted with CD45RBhi CD4+ T cellsPublished by Elsevier ,1994
- T helper type 1 development of naive CD4+ T cells requires the coordinate action of interleukin‐12 and interferon‐γ and is inhibited by transforming growth factor‐βEuropean Journal of Immunology, 1994
- Regulatory interactions between CD45RBhigh and CD45RBlow CD4+ T cells are important for the balance between protective and pathogenic cell-mediated immunity.The Journal of Experimental Medicine, 1994